Microbiology Testing/Clinical Microbiology Market - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2021 - 2026
Microbiology Testing/Clinical Microbiology Market Overview
The microbiology testing/clinical microbiology market size is estimated to reach $5.8 billion by 2026 and is poised to grow at a CAGR of 6.1% over the forecast period of 2021-2026. Clinical microbiology is the field of science and research that helps in understanding the nature of microbes or microbial identification, which has the potential to cause various forms of diseases. The study often involves discipline such as parasitology, a study of parasites and hosts, and their relationship amongst each other. Similarly, mycology refers to the scientific studies pertaining to fungi, which more commonly have mushrooms and yeasts; they help identify genetic and biochemical properties and assist one to understand the potential benefits and risks, it can exhibit in the human body. Additionally, the study of mycobacteriology has proved to exhibit various benefits. It is quintessential to know that mycobacteria do not possess an endospore and also lack capsules, although they have an outer membrane. The technological developments in disease diagnostics with a growing incidence of the disease-causing pathogen along with the rise in public-private investments are some of the factors driving the microbiology testing/clinical microbiology industry forward in the projected period of 2021-2026.
The report: “Microbiology Testing/Clinical Microbiology Market Forecast (2021-2026)”, by Industry ARC covers an in-depth analysis of the following segments of the Microbiology Testing/Clinical Microbiology Market.
By Product- Instruments, and Reagents.
By Disease- Respiratory Diseases, Bloodstream Infections, Gastrointestinal Infections, STDs, Urinary Tract Infections, and Others.
By Application- Pharmaceutical, Food Testing, Clinical, Energy, and Environmental.
By End Users- Customer Lab Service Providers, Hospital and Diagnostic Centres, and Research Laboratories and Academic Institutes.
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).
- Geographically, North America’s microbiology testing/clinical microbiology market held a dominant market share in the year 2020. It is owing to the rising incidences of epidemic outbreaks and the ready support by the government authorities in terms of budgetary and resource allocation. However, Asia-Pacific is set to grow at a lucrative pace in the projected period. It is owing to the recent advances being made in the study of various naturally occurring pathogens, which have the potential to create another pandemic like COVID-19.
- The technological developments in disease diagnostics with a growing incidence of the disease-causing pathogen is one of the drivers for the market. However, the operational barriers pertaining to diagnostic tests are a grave market challenge.
- A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Microbiology Testing/Clinical Microbiology Market Report.
Microbiology Testing/Clinical Microbiology Market- By Geography (%) for 2020.
Microbiology Testing/Clinical Microbiology Market Segmentation Analysis- By Application
The microbiology testing/ clinical microbiology market based on the application can be further segmented into Pharmaceutical, Food Testing, Clinical, Energy, and Environmental. The pharmaceutical segment held a dominant market share in the year 2020. It is owing to the pandemic-COVID 19. The disease was primarily diagnosed with the help of the RT-PCR technique, as the results obtained from such mechanisms were fast, and the error rate was explicitly low. Additionally, the prevalence of infectious diseases pre-pandemic was no less. As per CDC, 15.5 million visits made by patients to the doctor’s, were primarily diagnosed as infectious diseases. Additionally, the emergency department visits with infectious and parasitic infections were close to 3.4 million.
However, Food testing is estimated to be the fastest-growing with a CAGR of 6.6% over the forecast period of 2021-2026. It is owing to the rising inclination of people to eat “clean label” ingredient items. A clean label refers to maximum nutritious offerings along with following the practices of sustainability. Owing to genetic moderations being found in various food items, manufacturers are using the likes of PCR machines to test the product and certify it as “GMO-free.” Additionally, food-borne illness has been on the rise. As per WHO, 600 million annually fall ill due to consuming contaminated food.
Microbiology Testing/Clinical Microbiology Market Segmentation Analysis- By End Users
The microbiology testing/ clinical microbiology market based on the end-users can be further segmented into Customer Lab Service Providers, Hospital and Diagnostic Centres, and Research Laboratories, and Academic Institutes. The Hospitals and diagnostic centers held a dominant market share in the year 2020. It is owing to the high incidence of diseases such as TB, HIV-AIDS, and other diseases. Lately, Covid-19 provided an exponential surge in the following segment. For example, the number of covid cases globally has increased from 75 million (2020-December) to 208 million (August-2021).
Moreover, the hospital and diagnostic centers are estimated to be the fastest-growing, with a CAGR of 6.9% over the forecast period of 2021-2206. It is owing to the availability of technologically advanced products, which have reduced machine downtime, increased the throughput ratio. Additionally, the advent of technology has helped doctors and clinicians to rely on those test results, as they offer the advantages of molecular diagnostics products. Lastly, the hospitals are using PCR and other technologies to understand the version and genetic mutation within the virus class.
Microbiology Testing/Clinical Microbiology Market Segmentation Analysis- By Geography
The microbiology testing/clinical microbiology market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. Geographically, North America’s microbiology testing/clinical microbiology market held a dominant market share of 38% as compared to the other regions. It is owing to the demand created in multiple applications. Such as food testing, the demand created within the US is getting more and more customized and niche. For example, people's preferences are now relatable to obtaining vegan food. To add a sub-category within that, consumers are looking for products that are non-GMO, organic, and also follow sustainable practices. Additionally, the US spends a major portion of its GDP on healthcare advances, which in turn helps them in reducing the severity of diseases. For example, Pfizer received $1.95 billion for the research and development of Covid-19 vaccines by studying the genetic structure and creating a vaccine.
However, Asia-Pacific offers lucrative growth opportunities to the marketer. It is owing to the prevalence of infectious diseases in the demography. For example, 67% of the cases related to TB globally are provided by India, China, Pakistan, the Philippines, and others. Various government schemes and healthcare budgets have been aligned to counter such issues. For example, India saw a 137% increased healthcare spending allocation from 2019 owing to the pandemic and research-related activities relating to that. The following policies will help the market to grow substantially.
Microbiology Testing/Clinical Microbiology Market Drivers
technological advancements in diagnostic kits have helped the market to achieve
higher efficiency and low error rates.
Diagnostic kits or reagents are regularly being updated by the manufacturers to counter real-world problems and disease identifications. The technological benefits can be anything ranging from achieving a faster throughput ratio, a higher turnaround time with a lower error sampling rate. PCR, NGS, molecular cartridges are now suavely recognized for their higher efficiency, as they can run multitudes of samples in a single run. For example, the ABI quant studio 3D digital PCR system can run broad applications such as gene expression, regulation, and variation. Moreover, manufacturers are regularly updating the capacities also tweaking the systems as per the end-user requirement.
- The rise in the
cases of infectious diseases has helped the market to penetrate deeper and
Tuberculosis is caused by the bacteria known as mycobacterium tuberculosis and spreads via air and droplets. The cases of TB, although in developed countries, have stagnated. However, the following doesn’t hold true in low- and middle-income countries. As per WHO, the 30 high TB burden countries contribute to around 67% of the total cases globally. Moreover, there were around 66 million lives being saved between the last two decades. It is attributed to the growing technological diagnosis techniques such as PCR. The sample can be collected through blood by the process of venipuncture. Real-time PCRs have further eased the entire process. Additionally, the PCR technique was aggressively used during the COVID-19 pandemic. The pandemic has further helped the developers to create more robust machines, and the use of IoT to directly inform the affected patients has drastically helped the healthcare sector.
Microbiology Testing/Clinical Microbiology Market Challenges
- The operational
barriers pertaining to microbiological testing are an impending market
The patient sample can be collected using various techniques and forms such as via semen, saliva, tissue, blood, or stool. The samples used have an incredibly short time to get processed, failing to which the results so obtained can be ambiguous and not depict the right image. Hence, logistics play a vital role in supplementing market growth. For example, the blood sample should not remain in the room temperature/ outdoor settings for more than eight hours. Further, one can opt for refrigerating it at a temperature between 2 degrees to 8 degrees for seven days. Moreover, if one talks about PCR technology, it is extremely sensitive to contamination. A small amount of contamination might change the result status. Further, DNA polymerases are extremely pro to creating errors. The errors so created can potentially lead to mutation in PCR products, which can ultimately lead to contamination or further spread.
Microbiology Testing/Clinical Microbiology Market Competitive Landscape
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the microbiology testing/clinical microbiology market. The top 10- microbiology testing/clinical microbiology market companies include:
- Bio Meriux
- Danaher Corporation
- Becton, Dickinson, and Company
- Abbott Laboratories
- Roche Diagnostics
- Thermo Fischer Scientific
- Bio-Rad Laboratories
- Bruker Corporation
- In July 2021, Sanigen and Illumina announced a strategic partnership. In the following, the former will become the latter’s channel partner. Both the companies will work together to deliver Illumina’s NGS technology to the food safety and microbiology sector. The NGS panel has the capability to handle and detect 16 types of foodborne pathogens from around 400 samples.
- In March 2020, Thermo Scientific launched the SureTest PCR assays. The following launch was done owing to the recent surge in advocacy related to the non-consumption of genetically modified products. It is designed to detect foodborne pathogens quickly and accurately in a broad range of food, which by nature can be vegan and non-vegan.
Report Code- AGR 0003
Report Code- FBR 65808